Healx Overview

  • Founded

  • 2014

Founded
  • Status

  • Private

  • Employees

  • 171

Employees
  • Latest Deal Type

  • Series B

  • Latest Deal Amount

  • $55.5M

  • Investors

  • 18

Healx General Information

Description

Operator of an AI-powered, patient-inspired tech company intended to accelerate the discovery and development of treatments for rare diseases. The company's platform uses artificial intelligence to leverage the combination of algorithms to predict and de-risk novel connections in biomedical data and move the promising ones toward the clinic, enabling clinics to develop advanced treatment methods for rare disease remedies.

Contact Information

Website
www.healx.io
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Other Healthcare Technology Systems
Biotechnology
Primary Office
  • Charter House
  • 66-68 Hills Road
  • Cambridge CB2 1LA
  • England, United Kingdom
+44 01223 000000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Healx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series B) 16-Oct-2019 $55.5M 0000 00000 Completed Clinical Trials - General
5. Early Stage VC (Series A) 26-Jul-2018 000.00 000.00 Completed Clinical Trials - General
4. Early Stage VC (Series A) 05-Oct-2016 00.000 00.00 000.00 Completed Clinical Trials - General
3. Seed Round 15-Apr-2015 00000 00000 00.000 Completed Clinical Trials - General
2. Grant Completed Clinical Trials - General
1. Accelerator/Incubator 01-Jan-2015 Completed Clinical Trials - General
To view Healx’s complete valuation and funding history, request access »

Healx Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary 0,000 00.000000 0000.00 0000.00 00 0000.00 00.000
Ordinary 0,000 00.000000 0000.00 0000.00 00 0000.00 00.000
To view Healx’s complete cap table history, request access »

Healx Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of an AI-powered, patient-inspired tech company intended to accelerate the discovery and development of treatme
Drug Discovery
Cambridge, United Kingdom
171 As of 2023
0000
0000 0000-00-00
00000000000 0000

00000

elit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupida
0000 000000000
San Francisco, CA
00 As of 0000
00000
0000 0000-00-00
00000000000 00000

000000

dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla par
0000 000000000
Charlottesville, VA
00 As of 0000
00.000
0.000 0000-00-00
00000000000 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Healx Competitors (19)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Verge Genomics Venture Capital-Backed San Francisco, CA 00 00000 00000000000 00000
00000000 Venture Capital-Backed Charlottesville, VA 00 00.000 00000000000 00.000
00000 Venture Capital-Backed Paris, France 000 00000 00000000000 00000
000000000000 Formerly PE-Backed London, United Kingdom 000 00000 000000000 00000
00000000 00000000 Venture Capital-Backed Hong Kong, Hong Kong 00 00000 00000000000 00000
You’re viewing 5 of 19 competitors. Get the full list »

Healx Patents

  • 64

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 1

    Granted

  • 9

    Pending

  • 000

    Expiring in next 12 mo

Healx Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202218460-D0 Treatment Pending 08-Dec-2022
GB-202211265-D0 Crystals Pending 02-Aug-2022
GB-202211269-D0 Salts Pending 02-Aug-2022
GB-202210305-D0 Treatment of fragile x syndrome Pending 13-Jul-2022
GB-202116743-D0 Treatment Inactive 19-Nov-2021
To view Healx’s complete patent history, request access »

Healx Executive Team (21)

Name Title Board Seat Contact Info
Tim Guilliams Ph.D Co-Founder, Chief Executive Officer and Board Member
Gillian Bonthron Chief Financial Officer
Neil Thompson Ph.D Chief Scientific Officer
Bruce Bloom Chief Collaboration Officer
David Brown Ph.D Co-Founder & Chairman
You’re viewing 5 of 21 executive team members. Get the full list »

Healx Board Members (10)

Name Representing Role Since
Abdul Guefor Intel Capital Board Observer 000 0000
David Brown Ph.D Healx Co-Founder & Chairman 000 0000
Irina Haivas MD Atomico Board Member 000 0000
Jonathan Milner Self Board Member 000 0000
Shaun Grady Self Board Member 000 0000
You’re viewing 5 of 10 board members. Get the full list »

Healx Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Healx Investors (18)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
3e Capital Group Family Office Minority 000 0000 000000 0
Atomico Venture Capital Minority 000 0000 000000 0
btov Partners Venture Capital Minority 000 0000 000000 0
Global Brain Venture Capital Minority 000 0000 000000 0
Intel Capital Corporate Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 18 investors. Get the full list »

Healx Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 19-Aug-2017 0000000000 Business/Productivity Software
To view Healx’s complete acquisitions history, request access »

Ready to get started?

Request a free trial